Apogee Tx's corporate presentation

Client:

Apogee Therapeutics is a clinical-stage biotechnology company that discovers and develops novel therapies for a range of inflammatory and immunological diseases. The company seeks to achieve this by focusing on established biologic drivers of disease and applying advanced antibody engineering to create product candidates with optimized properties that may overcome the limitations of existing therapies.

Apogee Therapeutics is a clinical-stage biotechnology company that discovers and develops novel therapies for a range of inflammatory and immunological diseases. The company seeks to achieve this by focusing on established biologic drivers of disease and applying advanced antibody engineering to create product candidates with optimized properties that may overcome the limitations of existing therapies.

Client:

Uppsala University logo
Uppsala University logo

Project goal

We developed a flexible presentation template that served as the foundation for multiple decks tailored to different company needs, including event-specific presentations and a core corporate overview. Our objective was to design clear slides that translated Apogee’s biologic pipeline, clinical trial data, and long-acting dosing profiles in inflammatory and immunological diseases into a cohesive and confident framework. Across these efforts, we focused on clarifying complex trial designs, cross-study data, and long-term market opportunity for investors and partners while preserving scientific rigor, ultimately producing more than 150 slides.

Pipeline slide
Pipeline slide
Pipeline slide
Pipeline slide

Deck Highlights

Visual diagram of APG273 showing dual-pathway inhibition, molecular design, and pharmacologic differentiation
Visual diagram of APG273 showing dual-pathway inhibition, molecular design, and pharmacologic differentiation
Visual diagram of APG273 showing dual-pathway inhibition, molecular design, and pharmacologic differentiation
Visual diagram of APG273 showing dual-pathway inhibition, molecular design, and pharmacologic differentiation

APG279 co-formulation: molecular design and biomarker impact

“Visual Science produced an excellent result, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!”

“Visual Science produced an excellent result, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!”

	Noel Kurdi
	Noel Kurdi
	Noel Kurdi

VP, Investor Relations

The Process

Project timline:

4 weeks

Review:

2 zoom call + 5 e-mail feedback sessions

Team:

Find out which of our 26 scientific animation options works best for investor relations and communications:

Our design process was grounded in close collaboration with Apogee’s scientific and investor relations teams, as the scope extended beyond presenting the science alone. Apogee  required decks across extensive clinical data, market analysis, and strategic positioning, and our role was to unify this information into a cohesive visual system suitable for board and investor audiences.

We translated complex trial designs, biomarker data, and cross-study efficacy comparisons into a clear presentation using precise 2D data visualization and custom 3D antibody modeling. The deck includes standardized longitudinal efficacy charts, dosing interval and injection frequency visuals, pipeline and milestone timelines, and MoA graphics illustrating IL-13 inhibition and combination strategies.

Schematic and detailed 3D antibody visuals supported discussions of molecular design and differentiation. Developing a color-coding framework for numerous programs—while remaining within Apogee’s established visual identity—was a key challenge. All visuals were aligned with molecular animations we created for Apogee, ensuring consistency across static and animated scientific communications.

Outcome

The final corporate overview positioned Apogee as a differentiated biotechnology company across a broad range of inflammatory and immunological diseases. By clearly presenting clinical progress, long-acting dosing profiles, and pipeline strategy across programs, the deck reinforced Apogee’s scientific and strategic differentiation. The presentation supports key 2026 milestones, including Phase 2 readouts and planned Phase 3 initiation, while providing a strong foundation for investor engagement as Apogee advances towards a 2029 launch.

Contact us

Contact us

Contact us

Contact us

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

London

44 20 3734-2517

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

London

44 20 3734-2517

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

London

44 20 3734-2517

Address

200 Vesey Street, 24th floor, New York, NY 10281, USA

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

London

44 20 3734-2517

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

Visual Science Logo
Visual Science Logo
Visual Science Logo